ArticleInternational urogynecology journal2026
A Randomized Trial of Two Lightweight Polypropylene Meshes for Sacrocolpopexy.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisSacrocolpopexy is considered the most durable repair for apical pelvic organ prolapse. There are no data available to compare similar meshes used for sacrocolpopexy. The objective was to evaluate surgical success in women undergoing mesh sacrocolpopexy using two mesh grafts.
methodsThis is a randomized single-blind trial evaluating two ultra-lightweight Y mesh grafts used in laparoscopic sacrocolpopexy. Participants were randomized to one of two meshes and were blinded to arm assignment. Participants were followed for 2 years postoperatively. The primary outcome was surgical success defined as prolapse retreatment or patient-reported vaginal bulge. Validated questionnaires were used to assess patient-reported outcomes. Power analysis indicated 90 participants were needed.
resultsOne hundred six patients underwent laparoscopic sacrocolpopexy: 54 in the Restorelle® arm and 52 in the Vertessa® Lite arm. Mean age and BMI for all participants were 60±9 years, 28.1±5.2 kg/m
conclusionsIn this randomized comparison of two lightweight meshes for sacrocolpopexy, we demonstrated similar surgical success and low reoperation rates for both meshes. Two years postoperatively, minimally invasive sacrocolpopexy is associated with significant improvement in pelvic floor symptoms regardless of mesh used.
Indexed as
Identifiers
42766156What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.